Published in Nature, new clinical trial data for uveal melanoma therapy sparks hope for future patient solutionsMANHASSET, N.Y.--(BUSINESS WIRE)--Patients with metastatic uveal melanoma (UM), an aggressive eye cancer, often face a survival rate of less than two years once the disease spreads. While established treatment options are limited, to help patients living with this disease, more... The post Northwell Scientist Reveals Breakthrough Resul…